These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14709872)

  • 1. A new series of estrogen receptor modulators: effect of alkyl substituents on receptor-binding affinity.
    Kamada A; Sasaki A; Kitazawa N; Okabe T; Nara K; Hamaoka S; Araki S; Hagiwara H
    Chem Pharm Bull (Tokyo); 2004 Jan; 52(1):79-88. PubMed ID: 14709872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structural evaluation, and estrogen receptor interaction of 2,3-diarylpiperazines.
    Gust R; Keilitz R; Schmidt K
    J Med Chem; 2002 May; 45(11):2325-37. PubMed ID: 12014971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Phenylspiroindenes: a novel class of selective estrogen receptor modulators (SERMs).
    Blizzard TA; Morgan JD; Mosley RT; Birzin ET; Frisch K; Rohrer SP; Hammond ML
    Bioorg Med Chem Lett; 2003 Feb; 13(3):479-83. PubMed ID: 12565955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs).
    Wallace OB; Lauwers KS; Jones SA; Dodge JA
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1907-10. PubMed ID: 12749895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta.
    Minutolo F; Antonello M; Bertini S; Rapposelli S; Rossello A; Sheng S; Carlson KE; Katzenellenbogen JA; Macchia M
    Bioorg Med Chem; 2003 Apr; 11(7):1247-57. PubMed ID: 12628652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 2. Synthesis and estrogen receptor binding affinity of 4,4'-, 5,5'-, and 6,6'-disubstituted metahexestrols.
    Hartmann RW; Heindl A; Schönenberger H
    J Med Chem; 1984 May; 27(5):577-85. PubMed ID: 6325689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
    Tan Q; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3753-5. PubMed ID: 15203156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
    Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs.
    Chen HY; Kim S; Wu JY; Birzin ET; Chan W; Yang YT; Dahllund J; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 May; 14(10):2551-4. PubMed ID: 15109649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling.
    Hoekstra WJ; Patel HS; Liang X; Blanc JB; Heyer DO; Willson TM; Iannone MA; Kadwell SH; Miller LA; Pearce KH; Simmons CA; Shearin J
    J Med Chem; 2005 Mar; 48(6):2243-7. PubMed ID: 15771467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
    Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
    Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivatives.
    Smith HM; Knox AJ; Zisterer DM; Lloyd DG; Meegan MJ
    Med Chem; 2007 Mar; 3(2):135-55. PubMed ID: 17348852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
    von Angerer E; Strohmeier J
    J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.
    Jain N; Xu J; Kanojia RM; Du F; Jian-Zhong G; Pacia E; Lai MT; Musto A; Allan G; Reuman M; Li X; Hahn D; Cousineau M; Peng S; Ritchie D; Russell R; Lundeen S; Sui Z
    J Med Chem; 2009 Dec; 52(23):7544-69. PubMed ID: 19366247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs.
    Kim S; Wu J; Chen HY; Birzin ET; Chan W; Yang YT; Colwell L; Li S; Dahllund J; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2741-5. PubMed ID: 15125925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
    Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
    J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
    Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
    Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
    Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
    Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.